webinar register page

Webinar banner
Behind the Breakthroughs: New Hope, New Options for Lymphoid and Myeloid Blood Cancers
Join us on October 11 to learn about Dana-Farber’s leadership in drug development and one of the most promising therapies in a new class of drugs, venetoclax. Hear how your support plays a vital role in moving an idea from research to patient care and impacts patients across several blood cancer types.

Oct 11, 2022 02:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading